Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Charpentier

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
The Journal of Antimicrobial Chemotherapy|April 9, 2008
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavirB Masquelier, K L Assoumou, D Descamps, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2013
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 virusesS Lambert-Niclot, C Charpentier, A Storto, et al.
European Journal of Pediatrics|March 1, 1996
Clinical outcome and long-term management of 17 patients with propionic acidaemiaS B van der Meer, F Poggi, M Spada, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2018
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencingT Nguyen, D B Fofana, M P Lê, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2018
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)S Lambert-Niclot, M Grude, M L Chaix, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 15, 2018
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinantC Soulie, L Morand-Joubert, J Cottalorda, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide studyL Assoumou, C Charpentier, P Recordon-Pinson, et al.
Techniques in Coloproctology|January 10, 2024
Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practiceL Spindler, I Etienney, L Abramowitz, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 16, 2025
Management of women with abnormal cervical cytology: Update of French guidelines after the implementation of HPV screeningJ L Brun, C Bergeron, G Averous, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
The Journal of Antimicrobial Chemotherapy|April 9, 2008
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavirB Masquelier, K L Assoumou, D Descamps, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2013
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 virusesS Lambert-Niclot, C Charpentier, A Storto, et al.
European Journal of Pediatrics|March 1, 1996
Clinical outcome and long-term management of 17 patients with propionic acidaemiaS B van der Meer, F Poggi, M Spada, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2018
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencingT Nguyen, D B Fofana, M P Lê, et al.
The Journal of Antimicrobial Chemotherapy|May 3, 2018
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)S Lambert-Niclot, M Grude, M L Chaix, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 15, 2018
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinantC Soulie, L Morand-Joubert, J Cottalorda, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide studyL Assoumou, C Charpentier, P Recordon-Pinson, et al.
Techniques in Coloproctology|January 10, 2024
Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practiceL Spindler, I Etienney, L Abramowitz, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 16, 2025
Management of women with abnormal cervical cytology: Update of French guidelines after the implementation of HPV screeningJ L Brun, C Bergeron, G Averous, et al.
Pageof 21